Dmytro Shvets
Angel Investor @ Andreessen Horowitz
London, United Kingdom
Dmytro Shvets is a pre-seed investor at Andreessen Horowitz in London focused on Artificial Intelligence and Apps. Tech entrepreneur focused on on-device AI infrastructure. Currently building Mirai, on-device layer for AI model makers & products. Formerly co-founder & CEO of Reface, scaling consumer AI apps to 300M users. Board member at Endeavor Ukraine, a16z Scout, angel investor in startups including ElevenLabs, Dapper Labs, and others.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 9%
Last updated:
For AI agents: llms.txt
Industries Dmytro Shvets invests in
Stages Dmytro Shvets invests in
Countries Dmytro Shvets invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $1M–$11M
- Pre-Seed
- $200k–$1.4M
Investment Focus
Industry
- Artificial Intelligence 4 (36%)
- Apps 3 (27%)
- Software 3 (27%)
- Information Technology 2 (18%)
- SaaS 1 (9%)
Stage
- Pre-Seed 4 (36%)
- Seed 3 (27%)
- Series A 1 (9%)
- Series C 1 (9%)
- Venture - Series Unknown 1 (9%)
Country
- United States 4 (36%)
- United Kingdom 2 (18%)
- Canada 1 (9%)
- Poland 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| GRAI is an AI music research company building the intelligence layer for musical intent — transforming music from passive listening into social participation. | $9M / Seed / Apr 21, 2026 | ||
| Optic, an AI Drug Discovery company, is based in San Francisco. Our proprietary ligand-based and target-driven molecular search engine Bioptic.io identifies compounds by their activity-expressing fingerprints. It offers a novel approach to finding diverse candidate sets. In addition, we now also have an agentic AI platform for scientific andbusiness due diligence on drug assets. Our pipeline includes multiple pre-clinical stage programs, showcasing our commitment to practical, AI-driven solutions in cancer therapy. | $1M / Seed / Apr 10, 2025 | ||
| Yope app is the social "Google Photos" for Gen Z, designed for sharing and chatting, not just storage. | $4.7M / Seed / Feb 24, 2025 | ||
| Haz is an AI social commerce software that links friends based on the things they own. | $1.4M / Pre-Seed / May 21, 2024 | ||
| We identify mental health deviations at early stage by analyzing dream and user conversation patterns. | $200K / Pre-Seed / Jun 21, 2023 | ||
| Research Lab. Exploring new frontiers of voice generation. We are researching and deploying novel methods in voice AI to make content enjoyable in any language and voice to benefit new audiences and viewers. Our mission is to make content universally accessible in any language & voice. | $19M / Series A / Jun 20, 2023 | ||
| Optic, an AI Drug Discovery company, is based in San Francisco. Our proprietary ligand-based and target-driven molecular search engine Bioptic.io identifies compounds by their activity-expressing fingerprints. It offers a novel approach to finding diverse candidate sets. In addition, we now also have an agentic AI platform for scientific andbusiness due diligence on drug assets. Our pipeline includes multiple pre-clinical stage programs, showcasing our commitment to practical, AI-driven solutions in cancer therapy. | $11M / Seed / Jul 20, 2022 | ||
| donut is a social fintech application designed to connect donors, volunteers and nonprofits and facilitate donations in the U.S. and internationally. The company’s platform enables its customers to discover and donate to curated and vetted organizations, connect with like-minded individuals both in the consumer social environment and real world anddiscover new solutions to the problems they care about. | Pre-Seed / Jul 05, 2022 | ||
| Metatheory Inc. is an interactive technology and entertainment company building Web3 games, interactive content, social experiences, and other community-driven adventures. Metatheory’s mission is to inspire imagination by connecting people worldwide through immersive worlds built on cross-generational IP. | $1.5M / Venture - Series Unknown / Mar 10, 2022 | ||
| Metatheory Inc. is an interactive technology and entertainment company building Web3 games, interactive content, social experiences, and other community-driven adventures. Metatheory’s mission is to inspire imagination by connecting people worldwide through immersive worlds built on cross-generational IP. | Pre-Seed / Jan 13, 2022 | ||
| See all 11 investments → | |||
Co-Investors
About Andreessen Horowitz
Andreessen Horowitz supplies capital deployments across multiple development phases, ranging from early-stage seed investments to late-stage growth financing. Its specialized market coverage spans diverse sectors, including artificial intelligence, biological healthcare, consumer technologies, decentralized cryptocurrency networks, financial technology, and enterprise software infrastructure. Beyond capital allocations, the organization delivers operational support services by connecting corporate portfolio entities with a structured ecosystem of technical advisors, executive talent, and industry operators.
Andreessen Horowitz Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andrew Chen
General Partner
|
|||
Anish Acharya
General Partner
|
|||
David George
General Partner
|
|||
Emily Bennett
investing partner
|
|||
Gabriel Vasquez
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Featured in Investor Lists
Recommended lists
FAQ
What does Dmytro Shvets invest in?
Dmytro Shvets invests primarily in Artificial Intelligence, Apps and Software startups, most often at Pre-Seed and Seed stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Dmytro Shvets invest in?
Dmytro Shvets typically joins rounds of $1M–$11M at Seed and $200k–$1.4M at Pre-Seed. These are whole funding-round sizes, not Dmytro Shvets's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Dmytro Shvets took part in.
How do I contact Dmytro Shvets?
Public channels for Dmytro Shvets include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Dmytro Shvets last invest?
The most recent investment recorded for Dmytro Shvets closed in Apr 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
